APA Citatie

Westhovens, R., van Riel, P., Sibilia, J., Vratsanos, G., Nuamah, I., & Becker, J. (2004). Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment. BioMed Central.

Chicago Style citaat

Westhovens, R., P. van Riel, J. Sibilia, G. Vratsanos, I. Nuamah, en JC Becker. Abatacept (CTLA4Ig) Treatment Increases the Remission Rate in Rheumatoid Arthritis Patients Refractory to Methotrexate Treatment. BioMed Central, 2004.

MLA citatie

Westhovens, R., et al. Abatacept (CTLA4Ig) Treatment Increases the Remission Rate in Rheumatoid Arthritis Patients Refractory to Methotrexate Treatment. BioMed Central, 2004.